Tankyrase inhibition aggravates kidney injury in the absence of CD2AP

S Kuusela1, H Wang1, A A Wasik1

  • 1Department of Pathology, University of Helsinki, Helsinki, Finland.

Cell Death & Disease
|July 22, 2016
PubMed

Insights

CD2-associated protein (CD2AP) deficiency in podocytes sustains Wnt/β-catenin signaling, leading to kidney injury. Inhibiting tankyrase PARylation activity in CD2AP deficiency exacerbates kidney damage, highlighting the importance of PARylation balance.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • The Wnt/β-catenin pathway is implicated in podocyte injury and nephropathy.
  • Tankyrases antagonize Wnt/β-catenin signaling and interact with CD2-associated protein (CD2AP).
  • CD2AP is crucial for kidney ultrafiltration; its absence leads to kidney failure.

Purpose of the Study:

  • To investigate the role of tankyrases and CD2AP in podocyte function and kidney injury.
  • To explore the impact of tankyrase inhibition on Wnt/β-catenin signaling and podocyte damage in CD2AP-deficient models.

Main Methods:

  • Analysis of tankyrase-mediated poly(ADP-ribosyl)ation (PARylation) in CD2AP-knockout (CD2AP-/-) mice and cultured podocytes.
  • Assessment of β-catenin activity, LEF1, fibronectin, and PAI-1 expression.
  • Treatment with tankyrase inhibitor XAV939 in CD2AP-/- podocytes and zebrafish models.

Main Results:

  • CD2AP deficiency increased Wnt/β-catenin pathway activation, β-catenin activity, LEF1, and fibronectin in podocytes.
  • XAV939 treatment reduced PARylation and active β-catenin but worsened podocyte injury, increasing LEF1 and PAI-1.
  • XAV939 aggravated kidney injury and mortality in CD2AP-depleted zebrafish.

Conclusions:

  • Sustained Wnt/β-catenin pathway activation in CD2AP-/- podocytes contributes to kidney injury.
  • Inhibiting tankyrase PARylation activity in the absence of CD2AP is detrimental to kidney function.
  • CD2AP-mediated balance of tankyrase PARylation is essential for normal kidney function; targeting Wnt/β-catenin requires careful consideration in CD2AP-impaired kidney diseases.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
452
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
450
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
581
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
971
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K